MAA
HZNP

Managed Account Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Managed Account Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$11.5M Buy
330,753
+107,453
+48% +$3.28M 0.01% 1018
2015
Q1 		$5.8M Buy
223,300
+217,174
+3,545% +$3.98M 0.01% 1363
2014
Q4 		$79K Sell
6,126
-11,579
-65% -$145K ﹤0.01% 2419
2014
Q3 		$217K Buy
17,705
+4,186
+31% +$48.6K ﹤0.01% 2306
2014
Q2 		$214K Sell
13,519
-2,992
-18% -$42.7K ﹤0.01% 2286
2014
Q1 		$249K Buy
+16,511
New +$186K ﹤0.01% 2203

Other funds holding HZNP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
KCM
Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return